Filtered By:
Infectious Disease: Hepatitis

This page shows you your search results in order of relevance. This is page number 10.

Order by Relevance | Date

Total 33382 results found since Jan 2013.

Pretransplantation Portal Vein Recanalization and Transjugular Intrahepatic Portosystemic Shunt Creation for Chronic Portal Vein Thrombosis: Final Analysis of a 61-Patient Cohort
Conclusions PVR-TIPS is a safe, effective, and durable treatment option for patients with chronic PVT who need liver transplantation.
Source: Journal of Vascular and Interventional Radiology - October 31, 2017 Category: Radiology Source Type: research

Hepatitis C point-of-care diagnostics: in search of a single visit diagnosis.
Authors: Grebely J, Applegate TL, Cunningham P, Feld JJ Abstract INTRODUCTION: The availability of simple, tolerable, therapies for hepatitis C virus (HCV) infection with responses >95% is one of the greatest medical advances in decades, offering an opportunity to reverse the rising burden due to HCV and strive towards HCV elimination. A key challenge moving forward will be to ensure that those who are undiagnosed are made aware of their infection, receive HCV therapy and achieve viral cure. The availability of point-of-care tests for HCV infection has the potential to simplify testing algorithms, increase diagn...
Source: Expert Review of Molecular Diagnostics - November 2, 2017 Category: Laboratory Medicine Tags: Expert Rev Mol Diagn Source Type: research

Measuring Intrahepatic Vascular Changes Using Contrast-Enhanced Ultrasonography to Predict the Prognosis of Alcoholic Hepatitis Combined with Cirrhosis: A Prospective Pilot Study.
Conclusions: HVAT using microbubble CEUS could be a useful additional index to predict short-term mortality in patients with AH and cirrhosis. PMID: 29699059 [PubMed - as supplied by publisher]
Source: Gut and Liver - April 29, 2018 Category: Gastroenterology Tags: Gut Liver Source Type: research

Treatment of Hepatocellular Carcinoma with Tumor Thrombus with the Use of Iodine-125 Seed Strand Implantation and Transarterial Chemoembolization: A Propensity-Score Analysis
Conclusions 125I seed strand implantation combined with transarterial chemoembolization is a safe and effective treatment for HCC patients with portal vein invasion.
Source: Journal of Vascular and Interventional Radiology - May 11, 2018 Category: Radiology Source Type: research

IJERPH, Vol. 15, Pages 1432: In Search of Factors Negatively Affecting Vaccine Immunity to Pertussis in Preschool Children Before the Administration of the First Booster
Conclusions: Immunomodulation considered on the example of titre of IgG antibody to pertussis can serve as a useful model of the assessment of development of acquired immunity after mandatory vaccinations.
Source: International Journal of Environmental Research and Public Health - July 6, 2018 Category: Environmental Health Authors: Anna Bednarek Anna Bodajko-Grochowska Barbara Hasiec Robert Klepacz Katarzyna Szczekala Danuta Zarzycka Andrzej Emeryk Tags: Article Source Type: research

Treatment of Hepatocellular Carcinoma with Tumor Thrombus with the Use of Iodine-125 Seed Strand Implantation and Transarterial Chemoembolization: A Propensity-Score Analysis
Conclusions125I seed strand implantation combined with transarterial chemoembolization is a safe and effective treatment for HCC patients with portal vein invasion.
Source: Journal of Vascular and Interventional Radiology - July 10, 2018 Category: Radiology Source Type: research

Acute hemolytic pancreatitis and hepatitis secondary to percutaneous pharmacomechanical thrombectomy of prosthetic vascular access for hemodialysis.
Authors: Urdaneta J, Arroyo D, Mon C, Abadal J, Gálvez E, Ortiz M, Camacho R, Herrero JC PMID: 30119947 [PubMed - as supplied by publisher]
Source: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia - August 20, 2018 Category: Urology & Nephrology Tags: Nefrologia Source Type: research

Search of Hepatitis-B infection in relatives of chronic carriers in the province of Huanta, Ayacucho, Peru.
In conclusion, we found a high frequency of HBV in relatives of carriers of HBsAg. This strategy would help identify chronic carriers that can be treated and to contribute to a plan for the elimination of HBV. PMID: 30726419 [PubMed - in process]
Source: Revista Peruana de Medicina de Experimental y Salud Publica - February 7, 2019 Category: International Medicine & Public Health Tags: Rev Peru Med Exp Salud Publica Source Type: research

Abstract No. 610 Immunologic characterization of woodchuck hepatitis virus–induced hepatic tumors
Publication date: March 2019Source: Journal of Vascular and Interventional Radiology, Volume 30, Issue 3, SupplementAuthor(s): M. Mauda-Havakuk, W. Pritchard, A. Mikhail, O. Franco Mahecha, M. Starost, E. Jones, J. Esparza-Trujillo, I. Bakhutashvili, J. Karanian, B. Wood
Source: Journal of Vascular and Interventional Radiology - February 25, 2019 Category: Radiology Source Type: research

Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin in Hepatocellular Cancer with Extrahepatic Spread
ConclusionsHAIC is a potential treatment option for advanced HCC with limited extrahepatic metastases in a population with hepatitis B virus infection.
Source: Journal of Vascular and Interventional Radiology - February 27, 2019 Category: Radiology Source Type: research

Fifty years in search of selective antiviral drugs.
Abstract Fifty years of research (1968-2018) towards the identification of selective antiviral drugs have been primarily focused on antiviral compounds active against DNA viruses [i.e. herpes simplex virus (HSV), varicella-zoster virus (VZV), cytomegalovirus (CMV), hepatitis B virus (HBV)] and retroviruses [i.e. human immunodeficiency virus (HIV)]. For the treatment of HSV infections the aminoacyl esters of acyclovir were designed, one of which (the valine ester valacyclovir) became the successor of acyclovir in the treatment of HSV and VZV infections. BVDU (Brivudin) still stands out as the most effective among t...
Source: Herpes - April 1, 2019 Category: Infectious Diseases Authors: De Clercq E Tags: J Med Chem Source Type: research

An update on recent developments in the search for hepatitis C virus therapies with pan-genotypic efficacy.
Authors: Borgia G, Scotto R, Buonomo AR Abstract INTRODUCTION: Pangenotypic drugs against HCV infections led to high rates of virologic response with very limited adverse events. Moreover, they are easy to administer among all HCV genotypes with minimal changes in treatment schedule. For this reason, the demand for new antivirals is greatly lowered. Areas covered. We discuss results from trials assessing safety and efficacy of Ravidasvir, which is the only direct-acting antiviral currently in clinical development. Expert opinion. The currently available pangenotypic drug combinations are very effective in HCV eradi...
Source: Expert Opinion on Investigational Drugs - April 6, 2019 Category: Drugs & Pharmacology Tags: Expert Opin Investig Drugs Source Type: research

Pegylated interferon and ribavirin treatment for chronic hepatitis C deteriorates subclinical markers of vascular function.
Authors: Georgiopoulos G, Alexopoulou A, Pouriki S, Vasilieva L, Laina A, Bampatsias D, Mani I, Kontogiannis C, Tousoulis D, Stamatelopoulos K, Dourakis SP PMID: 31146885 [PubMed - as supplied by publisher]
Source: Hellenic Journal of Cardiology - June 1, 2019 Category: Cardiology Tags: Hellenic J Cardiol Source Type: research

Hepatic Artery Emboli Causing Fulminant Hepatitis
Publication date: October 2019Source: Journal of Vascular and Interventional Radiology, Volume 30, Issue 10Author(s): Mathieu Béland, Marc-Antoine Despatis, Gérald Gahide
Source: Journal of Vascular and Interventional Radiology - September 21, 2019 Category: Radiology Source Type: research